Ovarian cancer: A report from population-based cancer registry at central rural India
Ovarian neoplasms affect a huge part of the female population and, simultaneously, have the worst prognosis among all gynecological malignancies. In most of the population-based cancer registries (PBCR) in India, ovarian cancer is the third leading site of cancer among women, trailing behind cervix...
Gespeichert in:
| Veröffentlicht in: | Journal of cancer research and therapeutics 2023-12, Vol.19 (Suppl 2), p.S857-S862 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | S862 |
|---|---|
| container_issue | Suppl 2 |
| container_start_page | S857 |
| container_title | Journal of cancer research and therapeutics |
| container_volume | 19 |
| creator | Gangane, Nitin M Patil, Bharat U Ghongade, Pravinkumar V |
| description | Ovarian neoplasms affect a huge part of the female population and, simultaneously, have the worst prognosis among all gynecological malignancies. In most of the population-based cancer registries (PBCR) in India, ovarian cancer is the third leading site of cancer among women, trailing behind cervix and breast cancer.
In the present study, we have summarized the number of new cases of ovarian malignancy and its profile observed in the PBCR in central India during 7 years.
During a 7-year duration (2010-2016), 6,515 cancer patients were recorded at PBCR, and 228 cases were of ovarian malignancy. It was observed that most of the cases in this study were in 41-50 years of life. The age-standardized incidence rate of ovarian cancers in the present study was 4.61 per 100,000, and the crude incidence rate was 5.08 per 100,000. The crude mortality rate and age-standardized mortality rate of ovarian cancer were 2.3 and 2.02 per 100,000, respectively. Serous carcinoma was our study's most common histological subtype (43.75%), followed by mucinous carcinoma.
A steady increase has been observed in the incidence of ovarian cancer in several registries. A significant goal in managing ovarian cancer is to develop an effective test to detect the disease at its earlier stages, resulting in reduced mortality. |
| doi_str_mv | 10.4103/jcrt.jcrt_1426_22 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2930473143</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A788325029</galeid><sourcerecordid>A788325029</sourcerecordid><originalsourceid>FETCH-LOGICAL-c505t-9c8a5d59d670ebca3b3ff3470dba12d03009eb9b2ba4920421a17f4d33da11dc3</originalsourceid><addsrcrecordid>eNp9kk9r3DAQxUVpaTabfoBeiqGXXrzRaOS11NsS2jQQyCU5C1mSFy-25Ep2Id8-crP9yxIEI5B-b540PELeA91woHh5MHHaLEUBZ1vF2CuyAilFyQHFa7KissYSuGBn5DylA6VVzZh4S85QoOB0u12Rh7sfOnbaF0Z74-LnYldEN4Y4FW0MQzGGce711AVfNjo5e8Qys-_SFB8LPRXG-SnqvojzUm-87fQFedPqPrl3x31NHr5-ub_6Vt7eXd9c7W5LU9FqKqURurKVtNuausZobLBtkdfUNhqYpUipdI1sWKO5ZJQz0FC33CJaDWANrsmn575jDN9nlyY1dMm4vtfehTkpJpHyGoFjRj_-hx7CHH1-nUIAyKacVS9SFCWtoBbiD7XXvVOdb0MegFms1W65ZxXNzmtSnqD2zrs8p-Bd2-Xjf_jNCT4v64bOnBTAs8DEkFJ0rRpjN-j4qICqJSDqZzb-DkjWfDh-cG4GZ38rfiUCnwBzQrXe</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3039051788</pqid></control><display><type>article</type><title>Ovarian cancer: A report from population-based cancer registry at central rural India</title><source>Medknow Open Access Medical Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Gangane, Nitin M ; Patil, Bharat U ; Ghongade, Pravinkumar V</creator><creatorcontrib>Gangane, Nitin M ; Patil, Bharat U ; Ghongade, Pravinkumar V</creatorcontrib><description>Ovarian neoplasms affect a huge part of the female population and, simultaneously, have the worst prognosis among all gynecological malignancies. In most of the population-based cancer registries (PBCR) in India, ovarian cancer is the third leading site of cancer among women, trailing behind cervix and breast cancer.
In the present study, we have summarized the number of new cases of ovarian malignancy and its profile observed in the PBCR in central India during 7 years.
During a 7-year duration (2010-2016), 6,515 cancer patients were recorded at PBCR, and 228 cases were of ovarian malignancy. It was observed that most of the cases in this study were in 41-50 years of life. The age-standardized incidence rate of ovarian cancers in the present study was 4.61 per 100,000, and the crude incidence rate was 5.08 per 100,000. The crude mortality rate and age-standardized mortality rate of ovarian cancer were 2.3 and 2.02 per 100,000, respectively. Serous carcinoma was our study's most common histological subtype (43.75%), followed by mucinous carcinoma.
A steady increase has been observed in the incidence of ovarian cancer in several registries. A significant goal in managing ovarian cancer is to develop an effective test to detect the disease at its earlier stages, resulting in reduced mortality.</description><identifier>ISSN: 0973-1482</identifier><identifier>EISSN: 1998-4138</identifier><identifier>DOI: 10.4103/jcrt.jcrt_1426_22</identifier><identifier>PMID: 38384066</identifier><language>eng</language><publisher>India: Medknow Publications and Media Pvt. Ltd</publisher><subject>Demographic aspects ; Health aspects ; Mortality ; Ovarian cancer ; Patient outcomes ; Rural women ; Statistics</subject><ispartof>Journal of cancer research and therapeutics, 2023-12, Vol.19 (Suppl 2), p.S857-S862</ispartof><rights>Copyright © 2023 Copyright: © 2023 Journal of Cancer Research and Therapeutics.</rights><rights>COPYRIGHT 2023 Medknow Publications and Media Pvt. Ltd.</rights><rights>2023. This article is published under (http://creativecommons.org/licenses/by-nc-sa/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c505t-9c8a5d59d670ebca3b3ff3470dba12d03009eb9b2ba4920421a17f4d33da11dc3</citedby><cites>FETCH-LOGICAL-c505t-9c8a5d59d670ebca3b3ff3470dba12d03009eb9b2ba4920421a17f4d33da11dc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38384066$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gangane, Nitin M</creatorcontrib><creatorcontrib>Patil, Bharat U</creatorcontrib><creatorcontrib>Ghongade, Pravinkumar V</creatorcontrib><title>Ovarian cancer: A report from population-based cancer registry at central rural India</title><title>Journal of cancer research and therapeutics</title><addtitle>J Cancer Res Ther</addtitle><description>Ovarian neoplasms affect a huge part of the female population and, simultaneously, have the worst prognosis among all gynecological malignancies. In most of the population-based cancer registries (PBCR) in India, ovarian cancer is the third leading site of cancer among women, trailing behind cervix and breast cancer.
In the present study, we have summarized the number of new cases of ovarian malignancy and its profile observed in the PBCR in central India during 7 years.
During a 7-year duration (2010-2016), 6,515 cancer patients were recorded at PBCR, and 228 cases were of ovarian malignancy. It was observed that most of the cases in this study were in 41-50 years of life. The age-standardized incidence rate of ovarian cancers in the present study was 4.61 per 100,000, and the crude incidence rate was 5.08 per 100,000. The crude mortality rate and age-standardized mortality rate of ovarian cancer were 2.3 and 2.02 per 100,000, respectively. Serous carcinoma was our study's most common histological subtype (43.75%), followed by mucinous carcinoma.
A steady increase has been observed in the incidence of ovarian cancer in several registries. A significant goal in managing ovarian cancer is to develop an effective test to detect the disease at its earlier stages, resulting in reduced mortality.</description><subject>Demographic aspects</subject><subject>Health aspects</subject><subject>Mortality</subject><subject>Ovarian cancer</subject><subject>Patient outcomes</subject><subject>Rural women</subject><subject>Statistics</subject><issn>0973-1482</issn><issn>1998-4138</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kk9r3DAQxUVpaTabfoBeiqGXXrzRaOS11NsS2jQQyCU5C1mSFy-25Ep2Id8-crP9yxIEI5B-b540PELeA91woHh5MHHaLEUBZ1vF2CuyAilFyQHFa7KissYSuGBn5DylA6VVzZh4S85QoOB0u12Rh7sfOnbaF0Z74-LnYldEN4Y4FW0MQzGGce711AVfNjo5e8Qys-_SFB8LPRXG-SnqvojzUm-87fQFedPqPrl3x31NHr5-ub_6Vt7eXd9c7W5LU9FqKqURurKVtNuausZobLBtkdfUNhqYpUipdI1sWKO5ZJQz0FC33CJaDWANrsmn575jDN9nlyY1dMm4vtfehTkpJpHyGoFjRj_-hx7CHH1-nUIAyKacVS9SFCWtoBbiD7XXvVOdb0MegFms1W65ZxXNzmtSnqD2zrs8p-Bd2-Xjf_jNCT4v64bOnBTAs8DEkFJ0rRpjN-j4qICqJSDqZzb-DkjWfDh-cG4GZ38rfiUCnwBzQrXe</recordid><startdate>20231201</startdate><enddate>20231201</enddate><creator>Gangane, Nitin M</creator><creator>Patil, Bharat U</creator><creator>Ghongade, Pravinkumar V</creator><general>Medknow Publications and Media Pvt. Ltd</general><general>Medknow Publications & Media Pvt. Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20231201</creationdate><title>Ovarian cancer: A report from population-based cancer registry at central rural India</title><author>Gangane, Nitin M ; Patil, Bharat U ; Ghongade, Pravinkumar V</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c505t-9c8a5d59d670ebca3b3ff3470dba12d03009eb9b2ba4920421a17f4d33da11dc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Demographic aspects</topic><topic>Health aspects</topic><topic>Mortality</topic><topic>Ovarian cancer</topic><topic>Patient outcomes</topic><topic>Rural women</topic><topic>Statistics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gangane, Nitin M</creatorcontrib><creatorcontrib>Patil, Bharat U</creatorcontrib><creatorcontrib>Ghongade, Pravinkumar V</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of cancer research and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gangane, Nitin M</au><au>Patil, Bharat U</au><au>Ghongade, Pravinkumar V</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ovarian cancer: A report from population-based cancer registry at central rural India</atitle><jtitle>Journal of cancer research and therapeutics</jtitle><addtitle>J Cancer Res Ther</addtitle><date>2023-12-01</date><risdate>2023</risdate><volume>19</volume><issue>Suppl 2</issue><spage>S857</spage><epage>S862</epage><pages>S857-S862</pages><issn>0973-1482</issn><eissn>1998-4138</eissn><abstract>Ovarian neoplasms affect a huge part of the female population and, simultaneously, have the worst prognosis among all gynecological malignancies. In most of the population-based cancer registries (PBCR) in India, ovarian cancer is the third leading site of cancer among women, trailing behind cervix and breast cancer.
In the present study, we have summarized the number of new cases of ovarian malignancy and its profile observed in the PBCR in central India during 7 years.
During a 7-year duration (2010-2016), 6,515 cancer patients were recorded at PBCR, and 228 cases were of ovarian malignancy. It was observed that most of the cases in this study were in 41-50 years of life. The age-standardized incidence rate of ovarian cancers in the present study was 4.61 per 100,000, and the crude incidence rate was 5.08 per 100,000. The crude mortality rate and age-standardized mortality rate of ovarian cancer were 2.3 and 2.02 per 100,000, respectively. Serous carcinoma was our study's most common histological subtype (43.75%), followed by mucinous carcinoma.
A steady increase has been observed in the incidence of ovarian cancer in several registries. A significant goal in managing ovarian cancer is to develop an effective test to detect the disease at its earlier stages, resulting in reduced mortality.</abstract><cop>India</cop><pub>Medknow Publications and Media Pvt. Ltd</pub><pmid>38384066</pmid><doi>10.4103/jcrt.jcrt_1426_22</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0973-1482 |
| ispartof | Journal of cancer research and therapeutics, 2023-12, Vol.19 (Suppl 2), p.S857-S862 |
| issn | 0973-1482 1998-4138 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2930473143 |
| source | Medknow Open Access Medical Journals; EZB-FREE-00999 freely available EZB journals |
| subjects | Demographic aspects Health aspects Mortality Ovarian cancer Patient outcomes Rural women Statistics |
| title | Ovarian cancer: A report from population-based cancer registry at central rural India |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T01%3A06%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ovarian%20cancer:%20A%20report%20from%20population-based%20cancer%20registry%20at%20central%20rural%20India&rft.jtitle=Journal%20of%20cancer%20research%20and%20therapeutics&rft.au=Gangane,%20Nitin%20M&rft.date=2023-12-01&rft.volume=19&rft.issue=Suppl%202&rft.spage=S857&rft.epage=S862&rft.pages=S857-S862&rft.issn=0973-1482&rft.eissn=1998-4138&rft_id=info:doi/10.4103/jcrt.jcrt_1426_22&rft_dat=%3Cgale_proqu%3EA788325029%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3039051788&rft_id=info:pmid/38384066&rft_galeid=A788325029&rfr_iscdi=true |